EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives

• मुख्य लेखकों: Jiabao Hou (लेखक), Hongle Li (लेखक), Shuxiang Ma (लेखक), Zhen He (लेखक), Sen Yang (लेखक), Lidan Hao (लेखक), Hanqiong Zhou (लेखक), Zhe Zhang (लेखक), Jing Han (लेखक), Li Wang (लेखक), Qiming Wang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2022-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Platinum-based chemotherapy was previously the first-choice treatment for lung cancer. The discovery of epidermal growth factor receptor (EGFR) gene mutations and the development of EGFR tyrosine kinase inhibitors (TKIs) marked the beginning of the targeted therapy era for non-small-cell lu...